F. Vertessen

Evaluation of ADVIA 120 CSF assay (BayerR) vs. chamber counting of cerebrospinal fluid specimens

S. Mahieu, F. Vertessen, Marc van der Planken · Clinical & Laboratory Haematology · 2004 · 63 citations

Therapeutic Drug Monitoring, Csf Samples, Medicine +14

Haemostatic changes and acquired activated protein C resistance in normal pregnancy

B. Mahieu, Nadia Jacobs, Sarah Mahieu et al. · Blood Coagulation & Fibrinolysis · 2007 · 49 citations

A myelodysplastic syndrome preceding acute lymphoblastic leukaemia

Zwi Berneman, Dirk Van Bockstaele, Petra Meyer et al. · British Journal of Haematology · 1985 · 47 citations

Hematological Malignancy, Blastic Infiltration, Myelodysplastic Syndrome +12

Does pre-treatment with aspirin and loading dose clopidogrel obviate the need for glycoprotein IIb/IIIa antagonists during elective coronary stenting? A focus on peri-procedural myonecrosis†

Marc J. Claeys, M. G. Van der Planken, Johan Bosmans et al. · European Heart Journal · 2004 · 33 citations · Full text

Platelet Prothrombinase Activity, a Final Pathway Platelet Procoagulant Activity, Is Overexpressed in Type 1 Diabetes: No Relationship With Mean Platelet Volume or Background Retinopathy

M. G. Van der Planken, F. Vertessen, Jan Vertommen et al. · Clinical and Applied Thrombosis/Hemostasis · 2000 · 26 citations · Full text

Platelet Prothrombinase Activity, Immunology, Pathology +20